Table 2.
Combined Ablation (n=25) | Main Artery Ablation (n=25) | P Value | |
---|---|---|---|
Number of drug classes | 5.6±1.2 | 4.9±1.4 | 0.54 |
Five or more drug classes, % | 20 (80) | 15 (60) | 0.12 |
Angiotensin‐converting enzyme inhibitors, % | 6 (24) | 10 (40) | 0.23 |
Maximum dosage, % | 5 (20) | 7 (28) | 0.51 |
Angiotensin receptor antagonist, % | 19 (76) | 15 (60) | 0.23 |
Maximum dosage, % | 16 (72) | 13 (68) | 0.39 |
Renin antagonist, % | 1 (4) | 2 (8) | 0.55 |
Maximum dosage, % | 0 (0) | 2 (8) | 0.15 |
β‐Blockers, % | 22 (88) | 23 (92) | 0.64 |
Maximum dosage, % | 14 (56) | 12 (48) | 0.57 |
Calcium channel antagonists, % | 22 (88) | 18 (72) | 0.16 |
Maximum dosage, % | 19 (76) | 12 (48) | 0.041 |
Diuretics, % | 25 (100) | 22 (88) | 0.08 |
Maximum dosage, % | 16 (64) | 10 (40) | 0.09 |
Second diuretic, % | 5 (20) | 2 (8) | 0.22 |
Maximum dosage, % | 0 (0) | 0 (0) | n/a |
Aldosterone antagonists, % | 8 (32) | 2 (8) | 0.034 |
Maximum dosage, % | 7 (28) | 1 (4) | 0.021 |
Vasodilators, % | 2 (8) | 5 (20) | 0.22 |
Maximum dosage, % | 1 (4) | 3 (12) | 0.30 |
α‐Blockers, % | 9 (36) | 6 (24) | 0.36 |
Maximum dosage, % | 6 (24) | 5 (20) | 0.73 |
Centrally acting sympathicolytics, % | 17 (68) | 16 (64) | 0.52 |